These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1118 related items for PubMed ID: 1517576

  • 1. Tumor target-derived soluble factor synergizes with IFN-gamma and IL-2 to activate macrophages for tumor necrosis factor and nitric oxide production to mediate cytotoxicity of the same target.
    Jiang H, Stewart CA, Fast DJ, Leu RW.
    J Immunol; 1992 Sep 15; 149(6):2137-46. PubMed ID: 1517576
    [Abstract] [Full Text] [Related]

  • 2. IFN-gamma differentially modulates the susceptibility of L1210 and P815 tumor targets for macrophage-mediated cytotoxicity. Role of macrophage-target interaction coupled to nitric oxide generation, but independent of tumor necrosis factor production.
    Leu RW, Leu NR, Shannon BJ, Fast DJ.
    J Immunol; 1991 Sep 15; 147(6):1816-22. PubMed ID: 1909732
    [Abstract] [Full Text] [Related]

  • 3. Tumor-derived recognition factor (TDRF) induces production of TNF-alpha by murine macrophages, but requires synergy with IFN-gamma alone or in combination with IL-2 to induce nitric oxide synthase.
    Jiang H, Stewart CA, Fast DJ, Leu RW.
    Int J Immunopharmacol; 1996 Sep 15; 18(8-9):479-90. PubMed ID: 9023587
    [Abstract] [Full Text] [Related]

  • 4. Mechanistic differences between migration inhibitory factor (MIF) and IFN-gamma for macrophage activation. MIF and IFN-gamma synergize with lipid A to mediate migration inhibition but only IFN-gamma induces production of TNF-alpha and nitric oxide.
    Herriott MJ, Jiang H, Stewart CA, Fast DJ, Leu RW.
    J Immunol; 1993 May 15; 150(10):4524-31. PubMed ID: 7683323
    [Abstract] [Full Text] [Related]

  • 5. Reconstitution of a deficiency of AKR mouse macrophages for their response to lipid A activation for tumor cytotoxicity by complement subcomponent C1q: role of IFN-gamma.
    Leu RW, Zhou AQ, Rummage J, Fast DJ, Shannon BJ.
    J Immunol; 1991 Aug 15; 147(4):1315-21. PubMed ID: 1907994
    [Abstract] [Full Text] [Related]

  • 6. Role of tumor necrosis factor and interleukin 1 in gamma-interferon-promoted activation of mouse tumoricidal macrophages.
    Hori K, Mihich E, Ehrke MJ.
    Cancer Res; 1989 May 15; 49(10):2606-14. PubMed ID: 2496917
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Production of tumor necrosis factor by rIFN-gamma-primed C3H/HeJ (Lpsd) macrophages requires the presence of lipid A-associated proteins.
    Hogan MM, Vogel SN.
    J Immunol; 1988 Dec 15; 141(12):4196-202. PubMed ID: 3143760
    [Abstract] [Full Text] [Related]

  • 9. IFN-alpha beta reconstitutes the deficiency in lipid A-activated AKR macrophages for nitric oxide synthase.
    Jiang H, Rummage JA, Zhou A, Chen Z, Herriot MJ, Stewart CA, Kolosov M, Leu RW.
    J Immunol; 1996 Jul 01; 157(1):305-12. PubMed ID: 8683131
    [Abstract] [Full Text] [Related]

  • 10. Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-alpha production. Role of tumor-derived IL-10, TGF-beta, and prostaglandin E2.
    Alleva DG, Burger CJ, Elgert KD.
    J Immunol; 1994 Aug 15; 153(4):1674-86. PubMed ID: 8046239
    [Abstract] [Full Text] [Related]

  • 11. Interferon-gamma and interleukin-2 stimulate production of a soluble factor by L1210 and P815 tumor targets to promote macrophage activation.
    Jiang H, Robinson WE, Leu RW.
    Immunobiology; 1996 Jan 15; 195(1):91-104. PubMed ID: 8852603
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Taxol provides a second signal for murine macrophage tumoricidal activity.
    Manthey CL, Perera PY, Salkowski CA, Vogel SN.
    J Immunol; 1994 Jan 15; 152(2):825-31. PubMed ID: 7506736
    [Abstract] [Full Text] [Related]

  • 16. Potentiation of lymphokine-induced macrophage activation by tumor necrosis factor-alpha.
    Heidenreich S, Weyers M, Gong JH, Sprenger H, Nain M, Gemsa D.
    J Immunol; 1988 Mar 01; 140(5):1511-8. PubMed ID: 3126228
    [Abstract] [Full Text] [Related]

  • 17. The induction and augmentation of macrophage tumoricidal responses by platelet-activating factor.
    Howard AD, Erickson KL.
    Cell Immunol; 1995 Aug 01; 164(1):105-12. PubMed ID: 7634340
    [Abstract] [Full Text] [Related]

  • 18. Evidence for endogenous C1q modulates TNF-alpha receptor synthesis and autocrine binding of TNF-alpha associated with lipid A activation of murine macrophages for nitric oxide production.
    Jiang H, Rummage JA, Stewart CA, Herriott MJ, Kolosova I, Kolosov M, Leu RW.
    Cell Immunol; 1996 May 25; 170(1):34-40. PubMed ID: 8660797
    [Abstract] [Full Text] [Related]

  • 19. Transforming growth factor-beta 1 primes macrophages for enhanced expression of the nitric oxide synthase gene for nitric oxide-dependent cytotoxicity against Entamoeba histolytica.
    Lin JY, Seguin R, Keller K, Chadee K.
    Immunology; 1995 Jul 25; 85(3):400-7. PubMed ID: 7558128
    [Abstract] [Full Text] [Related]

  • 20. Cellular models of macrophage tumoricidal effector mechanisms in vitro. Characterization of cytolytic responses to tumor necrosis factor and nitric oxide pathways in vitro.
    Klostergaard J, Leroux ME, Hung MC.
    J Immunol; 1991 Oct 15; 147(8):2802-8. PubMed ID: 1918993
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 56.